- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/06 - Antimigraine agents
Patent holdings for IPC class A61P 25/06
Total number of patents in this class: 1312
10-year publication summary
|
28
|
34
|
71
|
73
|
100
|
104
|
105
|
109
|
91
|
94
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 276 |
64 |
| H. Lundbeck A/S | 1241 |
42 |
| Merck Sharp & Dohme LLC | 3734 |
36 |
| Allergan Pharmaceuticals International Limited | 233 |
35 |
| Eli Lilly and Company | 3898 |
25 |
| F. Hoffmann-La Roche AG | 7932 |
18 |
| Amgen Inc. | 4158 |
18 |
| Takeda Pharmaceutical Company Limited | 2717 |
18 |
| Bristol-myers Squibb Company | 4848 |
16 |
| Raqualia Pharma Inc. | 122 |
15 |
| Boehringer Ingelheim International GmbH | 4648 |
14 |
| Hoffmann-La Roche Inc. | 3516 |
12 |
| Janssen Pharmaceutica N.V. | 3349 |
11 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 151 |
11 |
| Intra-Cellular Therapies, Inc. | 415 |
9 |
| Taisho Pharmaceutical Co., Ltd. | 858 |
9 |
| Allergan, Inc. | 2315 |
8 |
| Teva Pharmaceuticals International GmbH | 333 |
8 |
| Vertex Pharmaceuticals Incorporated | 1623 |
7 |
| Dainippon Sumitomo Pharma Co., Ltd. | 180 |
7 |
| Other owners | 929 |